secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K/A
Filed at:   2024-09-11T23:59:59+00:00
Accession:  0001824293-24-000138
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 5.07, 3.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio receives Nasdaq deficiency notice for bid price below $1; 180-day cure period until March 10, 2025
--------------------------------------------------------------------------------

- Received Nasdaq letter on Sept 10, 2024 for failing minimum bid price of $1.00 over 30 consecutive business days.
- Has until March 10, 2025 (180 days) to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If stock closes at $0.10 or less for 10 consecutive trading days during cure period, Nasdaq may issue delisting determination.
- Company may be eligible for an additional 180-day extension if it meets other Nasdaq listing conditions.
- Management is monitoring the bid price and evaluating options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000138/0001824293-24-000138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000138/val-20240910.htm
  HTML page:      https://secwatch.observer/filing/0001824293-24-000138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer